Efficacy and initial dose determination of paricalcitol for treatment of secondary hyperparathyroidism in Chinese subjects

• Published in: Clinical nephrology Vol. 81; no. 1; p. 20
• Main Authors: Yan, Yucheng, Qian, Jiaqi, Chen, Nan, Huang, Zhaoxing, Jiang, Gengru, Li, Xuewang, Lin, Hongli, Liu, Liqiu, Wang, Mei, Xing, Changying, Yu, Xueqing, Zuo, Li, Amdahl, Michael, Khan, Samina
• Format: Journal Article
• Language: English
• Published: Germany 01.01.2014
• Subjects: Adult; Aged; Calcium - blood; Ergocalciferols - administration & dosage; Ergocalciferols - adverse effects; Ergocalciferols - therapeutic use; Female; Humans; Hyperparathyroidism, Secondary - blood; Hyperparathyroidism, Secondary - drug therapy; Male; Middle Aged; Parathyroid Hormone - blood; Phosphorus - blood; Single-Blind Method

Prevalence of secondary hyperparathyroidism (SHPT), a renal disease complication, is increasing in China. Available therapies may not optimally control SHPT, particularly in patients with hypercalcemia, hyperphosphatemia, and parathyroid hyperplasia. This study examined efficacy and safety of two do...